annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials. (PRNewsfoto/Telix Pharmaceuticals Limited)
The acquisition of Opt...
>>> Read more: Telix Acquires Optimal Tracers
The acquisition of Opt...
>>> Read more: Telix Acquires Optimal Tracers